Hologic, Inc. (VIE:HOLX)

Austria flag Austria · Delayed Price · Currency is EUR
64.50
0.00 (0.00%)
At close: Dec 5, 2025
-13.42%
Market Cap 14.31B
Revenue (ttm) 3.51B
Net Income (ttm) 483.79M
Shares Out n/a
EPS (ttm) 2.13
PE Ratio 29.58
Forward PE 16.31
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 64.50
Previous Close 64.50
Day's Range 64.50 - 64.50
52-Week Range 46.20 - 76.00
Beta n/a
RSI 57.74
Earnings Date Jan 30, 2026

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos... [Read more]

Industry X-Ray Apparatus and Tubes and Related Irradiation Apparatus
Founded 1985
Employees 7,070
Stock Exchange Vienna Stock Exchange
Ticker Symbol HOLX
Full Company Profile

Financial Performance

In 2025, Hologic's revenue was $4.10 billion, an increase of 1.74% compared to the previous year's $4.03 billion. Earnings were $565.70 million, a decrease of -28.35%.

Financial numbers in USD Financial Statements

News

There is no news available yet.